Lagricel Ofteno Ophthalmic Solution

· Laboratorios Sophia S.A de C.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lagricel Ofteno Ophthalmic Solution, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease. [Phase 2]

See pricing